Birth Defects
18
1
3
10
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
3 terminated out of 18 trials
76.9%
-9.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Study on Moebius Syndrome and Congenital Facial Weakness Disorders
Effectiveness of Comprehensive Tertiary Interventions on Incidence and Clinical Outcomes of Birth Defects
Genetic Inclusion by Virtual Evaluation
Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study
The Ma'Anshan Birth Cohort (MABC)
Uterine Fibroid Pregnancy Registry
The Ribavirin Pregnancy Registry
Personalized Genomic Research
Environmental Factors and Embryonic Development Project
Svangerskap, Arv, Og Miljo (Pregnancy, Heredity and Environment)
Clinical and Genetic Studies of VACTERL Association
Betaseron Pregnancy Registry
Influence of Genetics on Vitamin Metabolism in Pregnant Women
UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
The China-Anhui Birth Cohort Study (C-ABCS)
Developmental Delay in Children Exposed During Pregnancy to Either Lamotrigine,Sodium Valproate, or Carbamazepine
Pesticides--Health Fertility and Reproductive Risk